Quarterly report [Sections 13 or 15(d)]

FAIR VALUE MEASUREMENTS (Tables)

v3.25.3
FAIR VALUE MEASUREMENTS (Tables)
9 Months Ended
Sep. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis

The following table presents the balances of financial assets and liabilities measured at fair value on a recurring basis as of the periods ended (dollars in thousands):

    

Fair Value Measurements at September 30, 2025 using

    

    

Significant

    

    

Quoted Prices in

Other

Significant

Active Markets for

Observable

Unobservable

Identical Assets

Inputs

Inputs

Level 1

Level 2

Level 3

Balance

ASSETS

  

 

  

 

  

 

  

AFS securities:

  

 

  

 

  

 

  

U.S. government and agency securities

$

113,159

$

16,122

$

$

129,281

Obligations of states and political subdivisions

 

 

481,515

 

 

481,515

Corporate and other bonds(1)

 

 

246,155

 

 

246,155

MBS

 

 

3,408,640

 

 

3,408,640

Other securities

 

 

1,932

 

 

1,932

LHFS

 

 

24,772

 

 

24,772

Financial Derivatives(2)

 

 

110,293

 

 

110,293

LIABILITIES

Financial Derivatives(2)

$

$

170,694

$

$

170,694

(1) Other bonds include asset-backed securities.

(2) Includes hedged and non-hedged derivatives.

    

Fair Value Measurements at December 31, 2024 using

    

    

Significant

    

    

Quoted Prices in

Other

Significant

Active Markets for

Observable

Unobservable

Identical Assets

Inputs

Inputs

Level 1

Level 2

Level 3

Balance

ASSETS

  

 

  

 

  

 

  

AFS securities:

  

 

  

 

  

 

  

U.S. government and agency securities

$

62,199

$

3,814

$

$

66,013

Obligations of states and political subdivisions

 

 

468,337

 

 

468,337

Corporate and other bonds(1)

 

 

244,712

 

 

244,712

MBS

 

 

1,661,244

 

 

1,661,244

Other securities

 

 

1,860

 

 

1,860

LHFS

 

 

9,420

 

 

9,420

Financial Derivatives(2)

 

 

97,445

 

 

97,445

LIABILITIES

Financial Derivatives(2)

$

$

199,548

$

$

199,548

(1) Other bonds include asset-backed securities.

(2) Includes hedged and non-hedged derivatives.

Schedule of Financial Assets Measured at Fair Value on Nonrecurring Basis

The following tables summarize the Company’s financial assets that were measured on a nonrecurring basis as of the periods ended (dollars in thousands):

    

Fair Value Measurements at September 30, 2025 using

    

    

Significant

    

    

Quoted Prices in

Other

Significant

Active Markets for

Observable

Unobservable

Identical Assets

Inputs

Inputs

Level 1

Level 2

Level 3

Balance

ASSETS

Individually assessed loans(1)

$

$

$

1,736

$

1,736

(1) Net of reserves of $299,000 related to collateral dependent loans as of September 30, 2025.

Fair Value Measurements at December 31, 2024 using

    

    

Significant

    

    

Quoted Prices in

Other

Significant

Active Markets for

Observable

Unobservable

Identical Assets

Inputs

Inputs

Level 1

Level 2

Level 3

Balance

ASSETS

Individually assessed loans(1)

$

$

$

14,636

$

14,636

(1) Net of reserves of $13.1 million related to collateral dependent loans as of December 31, 2024.

Carrying Values and Estimated Fair Values of the Company's Financial Instruments

The carrying values and estimated fair values of the Company’s financial instruments as of the periods ended are as follows (dollars in thousands):

Fair Value Measurements at September 30, 2025 using

    

    

Quoted Prices

    

Significant

    

    

in Active

Other

Significant

Markets for

Observable

Unobservable

Total Fair

Identical Assets

Inputs

Inputs

Value

Carrying

 

Value

Level 1

Level 2

Level 3

Balance

ASSETS

Cash and cash equivalents

$

794,665

$

794,665

$

$

$

794,665

AFS securities

 

4,267,523

 

113,159

 

4,154,364

 

 

4,267,523

HTM securities

 

883,786

 

 

847,198

 

901

 

848,099

Restricted stock

 

159,320

 

 

159,320

 

 

159,320

LHFS

 

24,772

 

 

24,772

 

 

24,772

LHFI, net of deferred fees and costs

 

27,361,173

 

 

 

27,055,519

 

27,055,519

Financial Derivatives (1)

 

110,293

 

 

110,293

 

 

110,293

Accrued interest receivable

 

127,788

 

 

127,788

 

 

127,788

BOLI

 

669,102

 

 

669,102

 

 

669,102

LIABILITIES

 

  

 

  

 

  

 

  

 

  

Deposits

$

30,665,324

$

$

30,658,640

$

$

30,658,640

Borrowings

 

860,312

 

 

780,165

 

 

780,165

Accrued interest payable

 

22,128

 

 

22,128

 

 

22,128

Financial Derivatives (1)

 

170,694

 

 

170,694

 

 

170,694

(1) Includes hedged and non-hedged derivatives.

    

Fair Value Measurements at December 31, 2024 using

Quoted Prices

Significant

in Active

Other

Significant

Markets for

Observable

Unobservable

Total Fair

Identical Assets

Inputs

Inputs

Value

Carrying

Value

Level 1

Level 2

Level 3

Balance

ASSETS

Cash and cash equivalents

$

354,074

$

354,074

$

$

$

354,074

AFS securities

 

2,442,166

 

62,199

 

2,379,967

 

 

2,442,166

HTM securities

 

803,851

 

 

758,400

 

935

 

759,335

Restricted stock

 

102,954

 

 

102,954

 

 

102,954

LHFS

 

9,420

 

 

9,420

 

 

9,420

LHFI, net of deferred fees and costs

 

18,470,621

 

 

 

17,896,688

 

17,896,688

Financial Derivatives (1)

 

97,445

 

 

97,445

 

 

97,445

Accrued interest receivable

 

92,541

 

 

92,541

 

 

92,541

BOLI

 

493,396

 

 

493,396

 

 

493,396

LIABILITIES

 

  

 

  

 

  

 

  

 

  

Deposits

$

20,397,619

$

$

20,393,673

$

$

20,393,673

Borrowings

 

534,578

 

 

471,671

 

 

471,671

Accrued interest payable

 

26,214

 

 

26,214

 

 

26,214

Financial Derivatives (1)

 

199,548

 

 

199,548

 

 

199,548

(1) Includes hedged and non-hedged derivatives.